Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Antibiotic misuse in respiratory tract infections in children and adults-a prospective, multicentre study (TAILORED Treatment).

van Houten CB, Cohen A, Engelhard D, Hays JP, Karlsson R, Moore E, Fernández D, Kreisberg R, Collins LV, de Waal W, de Winter-de Groot KM, Wolfs TFW, Meijers P, Luijk B, Oosterheert JJ, Heijligenberg R, Sankatsing SUC, Bossink AWJ, Stubbs A, Stein M, Reisfeld S, Klein A, Rachmilevitch R, Ashkar J, Braverman I, Kartun V, Chistyakov I, Bamberger E, Srugo I, Odeh M, Schiff E, Dotan Y, Boico O, Navon R, Friedman T, Etshtein L, Paz M, Gottlieb TM, Pri-Or E, Kronenfeld G, Simon E, Oved K, Eden E, Bont LJ.

Eur J Clin Microbiol Infect Dis. 2019 Mar;38(3):505-514. doi: 10.1007/s10096-018-03454-2. Epub 2019 Feb 1.

2.

Stronger T cell immunogenicity of ovalbumin expressed intracellularly in Gram-negative than in Gram-positive bacteria.

Martner A, Ostman S, Lundin S, Rask C, Björnsson V, Telemo E, Collins LV, Axelsson L, Wold AE.

PLoS One. 2013 May 31;8(5):e65124. doi: 10.1371/journal.pone.0065124. Print 2013.

3.

CpG-containing oligodeoxynucleotides increases resistance of Anopheles mosquitoes to Plasmodium infection.

Silveira H, Gabriel A, Ramos S, Palma J, Felix R, Custódio A, Collins LV.

Insect Biochem Mol Biol. 2012 Oct;42(10):758-65. doi: 10.1016/j.ibmb.2012.07.003. Epub 2012 Jul 31.

PMID:
22885118
4.

The Veggie Project: a case study of a multi-component farmers' market intervention.

Freedman DA, Bell BA, Collins LV.

J Prim Prev. 2011 Aug;32(3-4):213-24. doi: 10.1007/s10935-011-0245-9.

PMID:
21805054
5.

Participatory organizational change in community-based health and human services: from tokenism to political engagement.

Bess KD, Prilleltensky I, Perkins DD, Collins LV.

Am J Community Psychol. 2009 Mar;43(1-2):134-48. doi: 10.1007/s10464-008-9222-8. Review.

PMID:
19142722
6.

Th17 development and autoimmune arthritis in the absence of reactive oxygen species.

George-Chandy A, Nordström I, Nygren E, Jonsson IM, Postigo J, Collins LV, Eriksson K.

Eur J Immunol. 2008 Apr;38(4):1118-26. doi: 10.1002/eji.200737348.

7.

Enhanced inflammatory responses of chronic granulomatous disease leukocytes involve ROS-independent activation of NF-kappa B.

Bylund J, MacDonald KL, Brown KL, Mydel P, Collins LV, Hancock RE, Speert DP.

Eur J Immunol. 2007 Apr;37(4):1087-96.

8.

Roles of the host oxidative immune response and bacterial antioxidant rubrerythrin during Porphyromonas gingivalis infection.

Mydel P, Takahashi Y, Yumoto H, Sztukowska M, Kubica M, Gibson FC 3rd, Kurtz DM Jr, Travis J, Collins LV, Nguyen KA, Genco CA, Potempa J.

PLoS Pathog. 2006 Jul;2(7):e76.

9.
10.

Phenotypic and functional characterization of human CD25+ B cells.

Brisslert M, Bokarewa M, Larsson P, Wing K, Collins LV, Tarkowski A.

Immunology. 2006 Apr;117(4):548-57.

11.
12.

Synergistic action of immunostimulatory DNA and fcgamma receptor IIB-crosslinking on B-cell phenotype and function.

Bjersing JL, Tarkowski A, Lundin S, Collins LV.

Immunobiology. 2005;210(1):23-32.

PMID:
16076031
13.

Immunostimulatory oligodeoxynucleotides induce dolphin neutrophil NADPH-oxidase activation in a CpG-independent but phosphorothioate backbone-dependent manner.

Itou T, Endo T, Sakai T, Karlsson A, Collins LV.

Dev Comp Immunol. 2005;29(7):583-8. Epub 2005 Jan 13.

PMID:
15784289
14.

Anti-proliferative effects of phosphodiester oligodeoxynucleotides.

Bjersing JL, Tarkowski A, Collins LV.

Immunobiology. 2004;209(8):637-45.

PMID:
15638132
15.

Impact of site-specific nucleobase deletions on the arthritogenicity of DNA.

Bjersing JL, Tarkowski A, Kandimalla ER, Karlsson H, Agrawal S, Collins LV.

Inflammation. 2004 Jun;28(3):159-68.

PMID:
15527171
17.

Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses.

Collins LV, Hajizadeh S, Holme E, Jonsson IM, Tarkowski A.

J Leukoc Biol. 2004 Jun;75(6):995-1000. Epub 2004 Feb 24.

PMID:
14982943
18.

Phytoestrogen genistein as an anti-staphylococcal agent.

Verdrengh M, Collins LV, Bergin P, Tarkowski A.

Microbes Infect. 2004 Jan;6(1):86-92.

PMID:
14738897
19.

Microbial superantigens as virulence factors and ways to counteract their actions.

Tarkowski A, Collins LV, Jonsson IM, Eriksson K, Sakiniene E, Verdrengh M.

Scand J Infect Dis. 2003;35(9):642-6. Review.

PMID:
14620148
20.

Extracellular mitochondrial DNA and oxidatively damaged DNA in synovial fluid of patients with rheumatoid arthritis.

Hajizadeh S, DeGroot J, TeKoppele JM, Tarkowski A, Collins LV.

Arthritis Res Ther. 2003;5(5):R234-40. Epub 2003 Jun 25.

21.

Inflammatogenic properties of bacterial DNA following cutaneous exposure.

Mölne L, Collins LV, Tarkowski A.

J Invest Dermatol. 2003 Aug;121(2):294-9.

22.

NADPH-oxidase activation in murine neutrophils via formyl peptide receptors.

Bylund J, Samuelsson M, Collins LV, Karlsson A.

Exp Cell Res. 2003 Jan 15;282(2):70-7.

PMID:
12531693
23.

Current status of pathogenetic mechanisms in staphylococcal arthritis.

Tarkowski A, Bokarewa M, Collins LV, Gjertsson I, Hultgren OH, Jin T, Jonsson IM, Josefsson E, Sakiniene E, Verdrengh M.

FEMS Microbiol Lett. 2002 Dec 17;217(2):125-32. Review.

24.
25.

Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice.

Collins LV, Kristian SA, Weidenmaier C, Faigle M, Van Kessel KP, Van Strijp JA, Götz F, Neumeister B, Peschel A.

J Infect Dis. 2002 Jul 15;186(2):214-9. Epub 2002 Jul 3.

PMID:
12134257
26.
27.

Mucosal tolerance to a bacterial superantigen indicates a novel pathway to prevent toxic shock.

Collins LV, Eriksson K, Ulrich RG, Tarkowski A.

Infect Immun. 2002 May;70(5):2282-7.

28.

Staphylococcal resistance to antimicrobial peptides of mammalian and bacterial origin.

Peschel A, Collins LV.

Peptides. 2001 Oct;22(10):1651-9. Review.

PMID:
11587793
29.

Model systems: modeling human staphylococcal arthritis and sepsis in the mouse.

Tarkowski A, Collins LV, Gjertsson I, Hultgren OH, Jonsson IM, Sakiniene E, Verdrengh M.

Trends Microbiol. 2001 Jul;9(7):321-6. Review.

PMID:
11435106
30.

Impact of transcription factors AP-1 and NF-kappaB on the outcome of experimental Staphylococcus aureus arthritis and sepsis.

Gjertsson I, Hultgren OH, Collins LV, Pettersson S, Tarkowski A.

Microbes Infect. 2001 Jun;3(7):527-34.

PMID:
11418326
31.

Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine.

Peschel A, Jack RW, Otto M, Collins LV, Staubitz P, Nicholson G, Kalbacher H, Nieuwenhuizen WF, Jung G, Tarkowski A, van Kessel KP, van Strijp JA.

J Exp Med. 2001 May 7;193(9):1067-76.

32.

Prevention of diseases caused by Staphylococcus aureus using the peptide RIP.

Balaban N, Collins LV, Cullor JS, Hume EB, Medina-Acosta E, Vieira da Motta O, O'Callaghan R, Rossitto PV, Shirtliff ME, Serafim da Silveira L, Tarkowski A, Torres JV.

Peptides. 2000 Sep;21(9):1301-11.

PMID:
11072116
33.

Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis.

Deng GM, Nilsson IM, Verdrengh M, Collins LV, Tarkowski A.

Nat Med. 1999 Jun;5(6):702-5.

PMID:
10371511
34.

Sequence of the phosphomannose isomerase-encoding gene of Salmonella typhimurium.

Collins LV, Hackett J.

Gene. 1991 Jul 15;103(1):135-6.

PMID:
1879695
36.

Mutations at rfc or pmi attenuate Salmonella typhimurium virulence for mice.

Collins LV, Attridge S, Hackett J.

Infect Immun. 1991 Mar;59(3):1079-85.

Supplemental Content

Loading ...
Support Center